Pharmacodynamics - PDFSEARCH.IO - Document Search Engine

Pharmacodynamics
Results: 131

#	Item
101	PDF Document Add to Reading List Source URL: media.wiley.com Language: English - Date: 2013-08-31 19:11:20 Medicinal chemistry Pharmacy Biotechnology Immunology Drug discovery Monoclonal antibodies Fusion protein Pharmacodynamics Etanercept Pharmaceutical sciences Pharmacology Medicine
102	PDF Document Add to Reading List Source URL: www.nature.com Language: English - Date: 2014-04-14 15:46:08 Cell biology Erythropoietin Continuous erythropoietin receptor activator Ligand Methoxy polyethylene glycol-epoetin beta Pharmacodynamics IC50 Potency Agonist Biology Erythropoiesis-stimulating agents Medicine
103	Figure 7: Decision tree to determine whether an investigational drug is an inhibitor of P-gp and when an in vivo clinical study is needed. A similar model can be applied to a BCRP inhibitor) — (Modified From Figures in Add to Reading List Source URL: www.fda.gov Language: English IC50 Pharmacodynamics
104	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Enzymes IC50 Pharmacodynamics Cytochrome P450 Chemistry Metabolism Biology
105	Lei Zang: Transporter DDI Evaluation in New Drug Application Submissions Add to Reading List Source URL: www.fda.gov Language: English Digoxin P-glycoprotein Pharmaceutical sciences Pharmacology IC50 Pharmacodynamics
106	Therapeutic Protein-Drug Interactions: an FDA Perspective Add to Reading List Source URL: www.fda.gov Language: English Pharmacokinetics Immunology Cytochrome P450 EC 1.14 Enzymes Monoclonal antibodies Pharmacodynamics In vitro Drug interaction Biology Anatomy Pharmaceutical sciences
107	Advisory Committee Mtgs. Sample PPT Add to Reading List Source URL: www.fda.gov Language: English IC50 Pharmacodynamics Biology Digoxin In vivo Enzyme In vitro Chemistry Pharmacology Metabolism
108	Draft — Not for Implementation For Discussion Purposes Only Drug Interaction Studies — Study Design, Data Analysis, and Implications for Dosing and Labeling Add to Reading List Source URL: www.fda.gov Language: English Pharmacokinetics Medicinal chemistry Pharmacy Metabolism Bioavailability Cytochrome P450 Drug interaction Pharmacodynamics Drug development Pharmaceutical sciences Pharmacology Chemistry
109	Draft — Not for Implementation For Discussion Purposes Only Drug Interaction Studies — Study Design, Data Analysis, and Implications for Dosing and Labeling Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-10-14 14:44:54 Pharmacokinetics Medicinal chemistry Pharmacy Metabolism Bioavailability Cytochrome P450 Drug interaction Pharmacodynamics Drug development Pharmaceutical sciences Pharmacology Chemistry
110	Curriculum Vitae: Jack Cook Add to Reading List Source URL: www.fda.gov Language: English Medicinal chemistry Clinical pharmacology Pharmacodynamics Pharmacist Pharmacy school Pharmaceutics Drug development Clinical pharmacy Pfizer Pharmaceutical sciences Pharmacy Pharmacology

UPDATE